Human papillomavirus 16/18 AS04-adjuvanted cervical cancer vaccine: Immunogenicity and safety in 15-25 years old healthy Korean women

  • Kim S
  • Song Y
  • Kim Y
 et al. 
  • 21


    Mendeley users who have this article in their library.
  • 9


    Citations of this article.


The study assessed the immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Korean women aged 15-25 years.

Author-supplied keywords

  • AS04-adjuvanted
  • Cervical cancer
  • Geometric mean titres
  • Human papillomavirus-16/18
  • Immunogenicity
  • Seroconversion

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • Seung Cheol Kim

  • Yong Sang Song

  • Young Tak Kim

  • Ki Sung Ryu

  • Bhavyashree Gunapalaiah

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free